1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Anasarca in 117 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (23.08) | 18.7374 |
1990's | 70 (59.83) | 18.2507 |
2000's | 9 (7.69) | 29.6817 |
2010's | 9 (7.69) | 24.3611 |
2020's | 2 (1.71) | 2.80 |
Authors | Studies |
---|---|
Ebina, K; Fukase, T; Sato, A | 1 |
Arifulin, EA; Azbukina, NV; Baksheeva, VE; Chistyakov, DV; Chistyakov, VV; Gancharova, OS; Goriainov, SV; Komarov, SV; Philippov, PP; Senin, II; Sergeeva, MG; Tikhomirova, NK; Tiulina, VV; Zamyatnin, AA; Zernii, EY | 1 |
Ebina, K; Ohta, R; Oikawa, K; Sato, A; Suzuki, T | 1 |
Akai, S; Egi, M; Higa, R; Ikari, A; Ishihara, T; Matsuyama, T; Miwa, M; Miyase, T; Sawairi, T; Sugatani, J; Yamaguchi, M; Yamazaki, Y; Yasuda, K | 1 |
Ebina, K; Oe, K; Sato, A; Yamanaka, H; Yokoyama, I | 1 |
Albrecht, M; Dombrowsky, H; Frerichs, I; Goldmann, T; Lautenschläger, I; Sarau, J; Uhlig, S; Weiler, N; Zitta, K | 1 |
Ebina, K; Sato, A; Yokoyama, I | 2 |
Goto, S; Itoh, H; Nagai, M; Ohmori, K; Osada, H; Sasaki, K; Shimizu, S; Shimoda, M; Shirai, J; Watanabe, M | 1 |
Bloechle, C; Izbicki, JR; Kaifi, J; Kluth, D; Mann, O; Schneider, C; Strate, T; Tiefenbacher, WJ; Yekebas, E | 1 |
Cândido, DM; Knysak, I; Kwasniewski, FH; Pereira, RL; Severino, DN | 1 |
Frey, M; Herndon, DH; Jeschke, MG; Kamolz, LP; Keck, M | 1 |
Aoki, J; Ebina, K; Kumagai, T; Sato, A | 1 |
Ebina, K; Sato, A | 1 |
Ashton, D; Fransen, JF; Hens, KA; Heylen, L; Hillen, LC; Janssens, F; Jurzak, MR; Leysen, JE; Mahieu, M; Megens, AA; Vermeire, JC; Vermote, PC | 1 |
Kulikov, VI; Muzya, GI | 1 |
Araújo, JG; Avelllar, MC; Calixto, JB; Campos, MM; Fernandes, ES; Passos, GF; Pesquero, JL; Teixeira, MM | 1 |
Calixto, JB; Campos, MM; de Souza, GE; Fernandes, ES; Fittipaldi, JF; Passos, GF; Pesquero, JL; Teixeira, MM | 1 |
Calixto, JB; Henriques, Md; Kassuya, CA; Menezes-de-Lima, O; Nascimento, AF | 1 |
Henson, PM; Murphy, RC; Reeves, JT; Simpson, J; Voelkel, NF; Worthen, S | 1 |
Goldenberg, MM; Meurer, RD | 1 |
Ferreira, SH; Vargaftig, BB | 1 |
Bessin, P; Bonnet, J; Loiseau, AM; Orvoen, M | 1 |
Chen, SF; Ruan, YJ | 1 |
McDonald, DM; Sulakvelidze, I | 1 |
Conde, JR; Martorell, J; Masso, JM; Villar, AM | 1 |
Autore, G; Capasso, F; Di Carlo, G; Di Urno, MV; Izzo, AA; Mascolo, N | 1 |
Antunes, E; Cirino, G; de Nucci, G; Donato, JL; Faro, R; Hyslop, S; Landucci, EC; Marangoni, S; Oliveira, B | 1 |
Inoue, H; Koshihara, Y; Nagata, N | 1 |
Bertrand, C; Desai, MC; Geppetti, P; Nadel, JA; Piedimonte, G; Snider, RM | 1 |
Asmawi, MZ; Kankaanranta, H; Moilanen, E; Vapaatalo, H | 1 |
Komatsu, H; Nagasawa, M; Okumoto, T | 1 |
Hellewell, PG; Teixeira, MM; Williams, TJ | 1 |
Das, A; Larkin, SW; Nourshargh, S; Williams, TJ | 1 |
Albert, DH; Carter, GW; Conway, RG; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Rhein, DA; Summers, JB; Tapang, P | 1 |
Amico-Roxas, M; Caruso, A; Cutuli, VM; De Bernardis, E; Leonardi, G | 2 |
Coffman, TM; Goulet, JL; Koller, BH; Latour, AM; Snouwaert, JN | 1 |
Bolanowski, MA; Nourshargh, S; Sanz, MJ; Weg, VB | 1 |
Nourshargh, S; Sanz, MJ; Walsh, DT; Weg, VB; Williams, TJ | 1 |
Fairbairn, SM; Hellewell, PG; Norman, KE; Rossi, AG; Teixeira, MM; Williams, TJ | 1 |
Mahmood, F; Rahman, NN; Saeed, SA; Simjee, RU | 1 |
Argenbright, LW; Norman, KE; Rossi, AG; Williams, TJ | 1 |
Filep, JG; Földes-Filep, E; Fournier, A | 1 |
Durán, WN; Hobson, RW; Yasuhara, H | 1 |
Bures, MG; Carrera, GM; Davidsen, SK; Guinn, DE; Heyman, HR; May, PD; Phillips, JG; Pireh, D; Sheppard, GS; Steinman, DH | 1 |
Patterson, JS; Provost, PJ; Stick, JA; Wilson, DV | 1 |
Catania, A; Ceriani, G; Lipton, JM; Macaluso, A | 1 |
Farnaz, S; Malik, A; Saeed, SA; Simjee, RU | 1 |
Ahluwalia, A; Perretti, M | 1 |
Doenhoff, MJ; Hellewell, PG; McNeice, C; Teixeira, MM; Williams, TJ | 1 |
Ahr, HJ; Beckermann, B; Bühner, K; Fruchtmann, R; Kohlsdorfer, C; Mohrs, KH; Müller-Peddinghaus, R; Perzborn, E; Theisen-Popp, P | 1 |
Bauer, J; Carlson, RP; Glaser, KB; Hartman, D; Holloway, D; Lock, YW; Sturm, R; Sung, A; Walter, T; Woeppel, S | 1 |
Amorim, CZ; Cordeiro, RS; Vargaftig, BB | 1 |
Lobb, RR; Nourshargh, S; Weg, VB; Williams, TJ | 1 |
Bozza, PT; Cordeiro, RS; Faria Neto, HC; Lima, MC; Martins, MA; Silva, PM; Sunkel, CE | 1 |
Norman, KE; Nourshargh, S; Pons, F; Rossi, AG; Williams, TJ | 1 |
Fukumura, D; Imaeda, H; Kurose, I; Miura, S; Sekizuka, E; Serizawa, H; Shiozaki, H; Suematsu, M; Tashiro, H; Tsuchiya, M | 1 |
Gunji, H; Harada, H; Hasegawa, T; Kaneko, F; Matsuzaki, M; Ono, I | 1 |
de Abreu Castro, MS; Dias, MF; Farinelli, P; Ferreira-Alves, DL; Francischi, JN; Kiyomi Funayama Tatsuo, MA; Pacheco, CM; Rocha, OA; Sirois, P | 1 |
Fischbarg, J; Kang, F; Kuang, K; Li, J; Zhu, Z | 1 |
Hellewell, PG; Macari, DM; Teixeira, MM | 1 |
Featherstone, RL; Uhlig, S; Wendel, A; Wilhelms, OH | 1 |
Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH | 1 |
Gilani, AH; Majoo, RU; Saeed, SA; Shah, BH | 1 |
Ekiz, F; Fincan, K; Haklar, G; Köksoy, F; Soybir, G; Yalçin, O; Yüksel, M | 1 |
Baqai, FT; Hamid, F; Shehnaz, D; Uddin Ahmad, V | 1 |
Allen, A; Davies, D; Haskard, DO; Larbi, K; Lobb, RR; Nourshargh, S; Sanz, M; Weg, VB | 1 |
Cai, X; Eckman, JB; Hwang, SB; Libertine-Garahan, L; Qian, C; Scannell, RT; Yeh, CG | 1 |
Hellewell, PG; Jose, PJ; Williams, TJ | 2 |
Amorim, CZ; Domont, GB; Moussatché, H; Perales, J; Rocha, SL | 1 |
Donigi-Gale, D; Edwards, R; Norman, KE; Rossi, AG; Shoupe, TS; Williams, TJ | 1 |
Bernat, A; Herbert, JM; Laplace, MC; Maffrand, JP; Salel, V | 1 |
Cordeiro, RS; Henriques, MG; Rae, GA; Williams, TJ | 1 |
Amorim, CZ; Cordeiro, RS; Martins, MA; Vargaftig, BB | 1 |
Amorim, CZ; Cordeiro, RS; Henriques, MG; Vargaftig, BB; Weg, VB | 1 |
Brain, SD; Buckley, TL; Collins, PD; Williams, TJ | 1 |
Teng, CM; Wang, JP | 1 |
Forn, J; García-Rafanell, J; Gómez, LA; Merlos, M; Vericat, L | 1 |
Hirasawa, N; Mue, S; Ohuchi, K; Omata, M; Tsurufuji, S; Watanabe, M | 1 |
Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Correa-Da-Silva, AC; Cruz, HN; Lima, MC; Martins, MA; Morhy, L; Perez, SA; Sousa, MV | 1 |
Forn, J; García-Rafanell, J; Giral, M; Gómez, LA; Merlos, M; Vericat, ML | 1 |
Oh-ishi, S; Qu, XF; Yamaki, K | 1 |
Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Correia-Da-Silva, AC; Martins, MA; Morhy, L; Sousa, MV | 1 |
Balmes, J; Fine, J; Gordon, T; Sheppard, D | 1 |
Buehn, MJ; Dabney, JM; Dobbins, DE | 1 |
Castro-Faria-Neto, HC; Cordeiro, RS; Henriques, MG; Martins, MA; Silva, PM; Silva, PS; Vargaftig, BB | 1 |
Chyczewski, L; Dabrowski, A; Gabryelewicz, A | 1 |
Barnes, PJ; Dijk, S; Rogers, DF | 1 |
Burstein, SH; Dewey, WL; Doyle, SA; Welch, SP | 1 |
Aliaga, M; Barbara, M; Bruniquel, F; Caillol, V; Delhon, A; N'Guyen, X; Puech, L; Tarayre, JP; Tisné-Versailles, J; Tisseyre, N | 1 |
Cordeiro, RS; Fernandes, PD; Henriques, MG; Martins, MA; Silva, PM; Vargaftig, BB; Weg, VB | 1 |
Hayashi, M; Oh-ishi, S; Qu, XF; Yamaki, K | 1 |
Kim, ED; Roth, SI; Stock, EL; Thamman, R; Walsh, MK | 1 |
Brain, SD; Williams, TJ | 1 |
Brown, NL; Fichelle, J; Jouquey, S; Worcel, M | 1 |
Browning, JL; Cirino, G; Flower, RJ; Peers, SH; Pepinsky, RB | 1 |
Fujii, T; Morimoto, H; Senoh, H | 1 |
Audette, CA; Burstein, SH; Doyle, SA; Hull, K; Hunter, SA; Latham, V | 1 |
Calixto, JB; Trebien, HA | 1 |
Hellewell, PG; Williams, TJ | 2 |
Reiter, MJ; Swingle, KF | 1 |
Cordeiro, RS; Martins, MA; Silva, PM | 1 |
Cordeiro, RS; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
Calhoun, W; Carlson, RP; Chang, J | 1 |
Peers, SH | 1 |
Castro-Faria-Neto, HC; Cordeiro, RS; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
Imai, T; Jacob, HS; Moldow, CF; Vercellotti, GM; Weir, EK | 1 |
Achterrath-Tuckermann, U; Szelenyi, I; Weischer, CH | 1 |
Rampart, M; Williams, TJ | 1 |
Castro, HC; Cordeiro, RS; Lima, MC; Martins, MA; Neto, F; Silva, PM; Vargaftig, BB | 1 |
Castanheira, JR; Cordeiro, RS; Faria Neto, HC; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
Cordeiro, RS; Henriques, MG; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
Hwang, SB; Lam, MH; Li, CL; Shen, TY | 1 |
Archer, CB; Guerreiro, D; Morley, J; Page, CP | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anasarca
Article | Year |
---|---|
Pathophysiology of burns.
Topics: Angiotensin II; Animals; Burns; Catecholamines; Edema; Hemodynamics; Histamine; Humans; Hypovolemia; Inflammation Mediators; Platelet Activating Factor; Prostaglandins; Serotonin; Skin; Soft Tissue Injuries; Thromboxanes; Vascular Resistance; Vasopressins | 2009 |
Proinflammatory activity of platelet-activating factor: pharmacological modulation and cellular involvement.
Topics: Blood Platelets; Edema; Humans; Inflammation; Leukocytes; Platelet Activating Factor | 1988 |
115 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anasarca
Article | Year |
---|---|
Biotinylated peptides substituted with D-amino acids with high stability as anti-anaphylactic agents targeting platelet-activating factor.
Topics: Amino Acids; Anaphylaxis; Animals; Edema; Hypothermia; Mice; Peptides; Platelet Activating Factor; Rats | 2022 |
Mechanisms and Treatment of Light-Induced Retinal Degeneration-Associated Inflammation: Insights from Biochemical Profiling of the Aqueous Humor.
Topics: Animals; Antioxidants; Aqueous Humor; Arachidonic Acid; Disease Models, Animal; Docosahexaenoic Acids; Edema; Inflammation; Light; Lipid Peroxidation; Macular Degeneration; Male; Mitochondria; Oxidative Stress; Oxylipins; Plastoquinone; Platelet Activating Factor; Rabbits; Retina; Retinal Degeneration | 2020 |
An endothelin-3-related synthetic biotinylated pentapeptide as a novel inhibitor of platelet-activating factor.
Topics: Amino Acid Sequence; Animals; Biotinylation; CD36 Antigens; Dose-Response Relationship, Drug; Edema; Endothelin-3; Male; Oligopeptides; Platelet Activating Factor; Rats; Rats, Wistar; Structure-Activity Relationship | 2013 |
A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
Topics: Acetyltransferases; Animals; Base Sequence; Benzoquinones; Carrageenan; Cells, Cultured; Cyclohexanones; DNA Primers; Edema; Male; Mice; Mice, Inbred C57BL; Penicillium; Platelet Activating Factor; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction | 2013 |
C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo.
Topics: Animals; C-Reactive Protein; Disease Models, Animal; Edema; Histamine; Inflammation Mediators; Male; Phospholipids; Platelet Activating Factor; Protein Binding; Rats; Rats, Wistar; Recombinant Proteins; Scavenger Receptors, Class E; Serotonin | 2014 |
Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.
Topics: Animals; Dexamethasone; Disease Models, Animal; Edema; Eicosanoids; Female; Gastrointestinal Diseases; Intestinal Mucosa; Paralysis; Platelet Activating Factor; Protective Agents; Quinidine; Rats; Vasoconstriction | 2015 |
Biotinylated heptapeptides substituted with a D-amino acid as platelet-activating factor inhibitors.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Biotinylation; Edema; Male; Oligopeptides; Platelet Activating Factor; Rats, Wistar | 2015 |
Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats.
Topics: Angiotensins; Animals; Edema; Inflammation; Male; Peptides; Platelet Activating Factor; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2015 |
Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs.
Topics: Animals; Azepines; Dogs; Edema; Erythema; Histamine; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prednisolone; Receptors, G-Protein-Coupled; Skin; Skin Diseases; Triazoles | 2016 |
Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
Topics: Amylases; Animals; Azepines; Capillaries; Cell Adhesion; Ceruletide; Disease Models, Animal; Edema; Female; Glycodeoxycholic Acid; Leukocytes; Microcirculation; Oligopeptides; Pancreas; Pancreatitis; Pancreatitis, Acute Necrotizing; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Regional Blood Flow; Severity of Illness Index; Taurocholic Acid; Time Factors; Triazoles | 2009 |
Edematogenic activity of scorpion venoms from the Buthidae family and the role of platelet-activating factor and nitric oxide in paw edema induced by Tityus venoms.
Topics: Animals; Edema; Hindlimb; Male; Mice; Nitric Oxide; Platelet Activating Factor; Scorpion Venoms; Scorpions; Species Specificity | 2009 |
Synthetic biotinylated peptide compounds derived from Asp-hemolysin: novel potent inhibitors of platelet-activating factor.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biotin; Biotinylation; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Fungal Proteins; Hemolysin Proteins; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Peptide Fragments; Peptides; Platelet Activating Factor; Rats; Rats, Wistar | 2012 |
Endothelin-3 at low concentrations attenuates inflammatory responses via the endothelin B2 receptor.
Topics: Animals; Edema; Endothelin-3; Inflammation; Male; Nitric Oxide; Platelet Activating Factor; Rats; Rats, Wistar; Receptor, Endothelin B; Zymosan | 2013 |
Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist.
Topics: Administration, Oral; Allergens; Animals; Butanols; Capsaicin; Cats; Dogs; Edema; Ferrets; Gerbillinae; Guinea Pigs; Histamine; Kinetics; Malates; Mice; Motor Activity; Neurokinin-1 Receptor Antagonists; Piperidines; Platelet Activating Factor; Rabbits; Receptors, Neurokinin-1; Salivation; Substance P; Time Factors | 2002 |
Influence of acyl and plasmalogenic analogs of platelet activating factor on chemotaxis of human leukocytes in vitro and their inflammatory and antiinflammatory activity in vivo.
Topics: Acylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Chemotaxis, Leukocyte; Disease Models, Animal; Edema; Hindlimb; Humans; Inflammation; Leukocytes; Plasmalogens; Platelet Activating Factor; Rats; Rats, Wistar; Time Factors | 2002 |
Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw.
Topics: Animals; Edema; Forelimb; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Wistar; Receptor, Bradykinin B1; RNA, Messenger; Up-Regulation | 2003 |
Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.
Topics: Animals; Cytokines; Edema; Interleukin-1; Male; Neutrophil Infiltration; Neutrophils; NF-kappa B; Peroxidase; Platelet Activating Factor; Rats; Rats, Wistar; Receptor, Bradykinin B1; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bradykinin; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Edema; Foot; Hindlimb; Histamine; Indomethacin; Injections, Intraperitoneal; Leukocytes; Lipoxins; Male; Mice; Neutrophil Infiltration; Oligopeptides; Platelet Activating Factor; Pleurisy; Receptors, Lipoxin | 2006 |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Edema; Lung; Male; Platelet Activating Factor; Pulmonary Circulation; Rats; Rats, Inbred Strains; SRS-A; Vasoconstriction | 1983 |
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat.
Topics: Animals; Carrageenan; Dexamethasone; Dose-Response Relationship, Drug; Edema; Hindlimb; Indomethacin; Male; Muscles; Phentolamine; Platelet Activating Factor; Rats; Rats, Inbred Strains; Regional Blood Flow; Theophylline; Verapamil; Yohimbine | 1984 |
Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors.
Topics: Animals; Aspirin; Carrageenan; Cyclooxygenase Inhibitors; Edema; Hyperalgesia; Indomethacin; Lysophosphatidylcholines; Platelet Activating Factor; Rats | 1981 |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Drug Interactions; Edema; Inflammation; Lysophosphatidylcholines; Pain; Platelet Activating Factor; Prostaglandins; Rats; Time Factors | 1981 |
1 alpha,25-Dihydroxyvitamin D3 decreases scalding- and platelet-activating factor-induced high vascular permeability and tissue oedema.
Topics: Animals; Burns; Calcitriol; Capillary Permeability; Edema; Hindlimb; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1995 |
Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Afferent Pathways; Animals; Bradykinin; Capillary Permeability; Capsaicin; Dose-Response Relationship, Drug; Edema; Endothelium, Vascular; Ethanolamines; Formoterol Fumarate; Injections, Intravenous; Male; Platelet Activating Factor; Premedication; Rats; Rats, Inbred F344; Substance P; Trachea; Tracheal Diseases | 1994 |
Effect of fepradinol on rat hind paw oedema induced by several inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dextrans; Edema; Ethanolamines; Foot; Kaolin; Male; Nystatin; Platelet Activating Factor; Rats; Rats, Wistar | 1993 |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
Topics: Animals; Bradykinin; Carrageenan; Cellulose; Dextrans; Dinoprostone; Diterpenes; Drug Synergism; Edema; Ginkgolides; Histamine; Inflammation Mediators; Lactones; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Verapamil | 1994 |
Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Arachidonic Acid; Carrageenan; Cell Degranulation; Crotoxin; Disease Models, Animal; Edema; Guinea Pigs; Histamine Release; Humans; Injections, Intraperitoneal; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Wistar; Serotonin; Thromboxane B2 | 1995 |
Inhibition by actinomycin D of neurogenic mouse ear oedema.
Topics: Animals; Bradykinin; Calcimycin; Calcitonin Gene-Related Peptide; Capsaicin; Cycloheximide; Dactinomycin; Disease Models, Animal; Dose-Response Relationship, Drug; Doxorubicin; Ear Diseases; Edema; Histamine; Injections, Intravenous; Leukotriene C4; Male; Mast Cells; Mice; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Substance P; Tachykinins; Vasoactive Intestinal Peptide | 1995 |
A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.
Topics: Animals; Capillary Permeability; Capsaicin; Dose-Response Relationship, Drug; Edema; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Hypertonic Solutions; Neurokinin A; Neurons, Afferent; Piperidines; Platelet Activating Factor; Rats; Rats, Inbred F344; Receptors, Neurotransmitter; Receptors, Tachykinin; Sodium Chloride; Stimulation, Chemical; Substance P; Trachea; Tracheal Diseases | 1993 |
Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Chemistry Techniques, Analytical; Dextrans; Edema; Leukotriene B4; Methanol; Neutrophils; Plant Extracts; Plants, Medicinal; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Water | 1993 |
Inhibition of leukocyte adhesion to endothelial cells of human umbilical vein by Y-24180, an antagonist of platelet-activating factor.
Topics: Animals; Antigens, CD; Azepines; CD18 Antigens; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; E-Selectin; Edema; Endothelium, Vascular; Guinea Pigs; Humans; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Triazoles; Umbilical Veins | 1993 |
E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin.
Topics: Alprostadil; Animals; Dinoprostone; Edema; Eosinophils; Guinea Pigs; Iloprost; In Vitro Techniques; Indium Radioisotopes; Isoproterenol; Male; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Prostaglandins E; Skin; Zymosan | 1993 |
Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor.
Topics: Animals; Azepines; Cell Adhesion; Chemotaxis, Leukocyte; Dihydropyridines; Edema; Imidazoles; Inflammation; Interleukin-1; Leukocytes; Male; Mesentery; Microcirculation; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Skin; Triazoles | 1995 |
ABT-299, a potent antagonist of platelet activating factor.
Topics: Animals; Binding, Competitive; Blood Pressure; Edema; Esterases; Humans; Hypotension; Indoles; Kinetics; Lipopolysaccharides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Thiazoles | 1995 |
Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema.
Topics: Animals; Cardiotonic Agents; Carnitine; Carrageenan; Dose-Response Relationship, Drug; Edema; Indomethacin; Male; Phenylbutazone; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Altered inflammatory responses in leukotriene-deficient mice.
Topics: Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Chemotaxis, Leukocyte; Dinoprostone; Edema; Inflammation; Leukotriene C4; Leukotrienes; Macrophages; Mice; Mice, Knockout; Neutrophils; Platelet Activating Factor; Thromboxane B2 | 1994 |
IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody.
Topics: Animals; Antibodies, Monoclonal; Calcium; Chemotaxis, Leukocyte; Dactinomycin; Dihydropyridines; Edema; Eosinophils; Imidazoles; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Leukotriene B4; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sialoglycoproteins; Skin | 1995 |
Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Topics: Animals; Blood Proteins; Calcium; Dihydropyridines; Edema; Eosinophils; Female; Guinea Pigs; Imidazoles; Leukotriene B4; Neutrophils; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Zymosan | 1994 |
Protective effects of papaverine salicylate in mouse ear dermatitis and PAF-induced rat paw oedema.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cantharidin; Croton Oil; Dermatitis; Dose-Response Relationship, Drug; Ear, External; Edema; Male; Mice; Papaverine; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Zymosan | 1994 |
Studies on the mechanisms involved in the inflammatory response in a reversed passive Arthus reaction in guinea-pig skin: contribution of neutrophils and endogenous mediators.
Topics: Animals; Anti-Inflammatory Agents; Arthus Reaction; CD18 Antigens; Edema; Guinea Pigs; Histamine H1 Antagonists; Indium Radioisotopes; Inflammation; Inflammation Mediators; Leukocytes; Lipoxygenase Inhibitors; Neutrophils; Nitric Oxide; Platelet Activating Factor; Rabbits; Skin; Zymosan | 1994 |
Dual inhibition of platelet-activating factor and arachidonic acid metabolism by ajmaline and effect on carrageenan-induced rat paw oedema.
Topics: Ajmaline; Animals; Arachidonic Acid; Aspirin; Blood Platelets; Carbon Radioisotopes; Carrageenan; Edema; Humans; Indomethacin; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Shock | 1993 |
Role of adhesion glycoproteins CD18 and intercellular adhesion molecule-1 in complement-mediated reactions of rabbit skin.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Arthus Reaction; Bradykinin; CD18 Antigens; Cell Adhesion Molecules; Dinoprostone; Dogs; Edema; Hemorrhage; Humans; Intercellular Adhesion Molecule-1; Mice; Platelet Activating Factor; Rabbits; Receptors, Leukocyte-Adhesion; Skin; Zymosan | 1994 |
Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Topics: Anesthesia; Animals; Blood Pressure; Capillary Permeability; Edema; Electrocardiography; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Male; Myocardial Ischemia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Endothelin; Receptors, G-Protein-Coupled; Receptors, Thromboxane; Thromboxane A2 | 1994 |
Platelet-activating factor causes venular constriction in the microcirculation.
Topics: Animals; Cheek; Cricetinae; Disease Models, Animal; Edema; Hemodynamics; Male; Mesocricetus; Platelet Activating Factor; Vasoconstriction; Venules | 1994 |
3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
Topics: Administration, Oral; Animals; Capillary Permeability; Edema; In Vitro Techniques; Indoles; Magnetic Resonance Spectroscopy; Male; Mice; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Serotonin; Skin; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 1994 |
Histologic and ultrastructural changes after large-colon torsion, with and without use of a specific platelet-activating factor antagonist (WEB 2086), in ponies.
Topics: Animals; Azepines; Colon; Colonic Diseases; Edema; Epithelium; Female; Horse Diseases; Horses; Intestinal Mucosa; Male; Microscopy, Electron; Necrosis; Neutrophils; Platelet Activating Factor; Torsion Abnormality; Triazoles | 1994 |
Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Edema; Female; Inflammation; Injections, Intraventricular; Interleukin-1; Interleukin-8; Leukotriene B4; Mice; Mice, Inbred BALB C; Platelet Activating Factor | 1994 |
Triterpenes and B-sitosterol from piper betle: isolation, antiplatelet and anti-inflammatory effects.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Areca; Aspirin; Chromatography, Liquid; Edema; Humans; Plants, Medicinal; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Sitosterols; Triterpenes | 1993 |
Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood; Dinoprostone; Edema; Male; Mice; Misoprostol; Platelet Activating Factor; Rats; Rats, Wistar; Receptors, Prostaglandin E; Skin; Zymosan | 1994 |
Mechanisms of the inflammatory response induced by extracts of Schistosoma mansoni larvae in guinea pig skin.
Topics: Animals; Bradykinin; Dermatitis; Edema; Eosinophils; Female; Guinea Pigs; Larva; Platelet Activating Factor; Protease Inhibitors; Schistosoma mansoni | 1993 |
BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
Topics: Animals; Biological Assay; Edema; Female; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Pleurisy; Protein Binding; Quinolines; Rats | 1993 |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoconstriction; Edema; Guinea Pigs; Humans; Indomethacin; Leukotrienes; Lipoxygenase Inhibitors; Macrophages; Male; Mice; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prostaglandins E; Quinolines | 1993 |
Interference of PCA 4248, a novel PAF receptor antagonist, with antigen-induced paw edema in mice.
Topics: Animals; Dihydropyridines; Edema; Injections, Intraperitoneal; Male; Mice; Ovalbumin; Platelet Activating Factor | 1993 |
A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo.
Topics: Animals; Antibodies, Monoclonal; Edema; Eosinophils; Guinea Pigs; Inflammation; Leukotriene B4; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Receptors, Very Late Antigen; Zymosan | 1993 |
Interference of the PAF receptor antagonist, PCA 4248, with the rat pleurisy evoked by inflammatory mediators or allergen.
Topics: Allergens; Animals; Bradykinin; Dihydropyridines; Edema; Eosinophils; Exudates and Transudates; Female; Histamine; Hypersensitivity; Leukocyte Count; Male; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pleurisy; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Serotonin | 1993 |
Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Topics: Animals; Arthus Reaction; Blood Platelets; Calcium; Dihydropyridines; Edema; Fura-2; Imidazoles; In Vitro Techniques; Indium Radioisotopes; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serum Albumin; Skin; Zymosan | 1993 |
Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid.
Topics: Animals; Blood Flow Velocity; Cell Adhesion; Edema; Eicosapentaenoic Acid; Endotoxins; Erythrocytes; Escherichia coli; Fatty Acids; Ileum; Intestinal Mucosa; Leukocytes; Male; Microcirculation; Phospholipids; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Venules | 1993 |
Effects of a platelet activating factor antagonist on oedema formation following burns.
Topics: Animals; Body Water; Burns; Edema; Isoquinolines; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Skin; Superoxide Dismutase; Tetrahydroisoquinolines | 1993 |
Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.
Topics: Animals; Bradykinin; Cyclosporine; Dexamethasone; Dextrans; Diterpenes; Edema; Ginkgolides; Histamine; Immunosuppressive Agents; Inflammation Mediators; Injections, Intravenous; Lactones; Male; Methysergide; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Polyenes; Rats; Serotonin; Serotonin Antagonists; Sirolimus | 1996 |
Platelet activating factor inhibits fluid transport by corneal endothelium.
Topics: Animals; Cattle; Cells, Cultured; Diterpenes; Edema; Electric Conductivity; Endothelium, Corneal; Ginkgolides; Kinetics; Lactones; Platelet Activating Factor; Rabbits; Stromal Cells | 1996 |
Priming of eosinophil recruitment in vivo by LPS pretreatment.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Azepines; CD18 Antigens; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a, des-Arginine; Cycloheximide; Drug Synergism; Edema; Eosinophilia; Eosinophils; Female; Guinea Pigs; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Leukocyte Count; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Synthesis Inhibitors; Pyrans; Quinolones; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sialoglycoproteins; Skin; Triazoles; Zymosan | 1996 |
Effect of urodilatin on platelet-activating factor-induced bronchoconstriction, vasoconstriction and edema formation in isolated rat lung.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Bronchoconstriction; Bronchodilator Agents; Capillary Permeability; Edema; Female; Lung; Organ Size; Peptide Fragments; Perfusion; Platelet Activating Factor; Rats; Rats, Wistar; Thromboxanes; Vascular Resistance; Vasoconstriction | 1996 |
Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses.
Topics: 5-Lipoxygenase-Activating Proteins; Anaphylaxis; Animals; Arachidonic Acid; Carrier Proteins; DNA, Complementary; Edema; Eicosanoids; Hypersensitivity, Delayed; Immunoglobulin E; Inflammation; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Peritonitis; Peroxidase; Platelet Activating Factor; RNA, Messenger; Transcription, Genetic; Zymosan | 1997 |
Anti-thrombotic and anti-inflammatory activities of protopine.
Topics: Adenosine Diphosphate; Alkaloids; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Benzophenanthridines; Berberine Alkaloids; Blood Platelets; Carrageenan; Edema; Fibrinolytic Agents; Histamine H1 Antagonists; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rabbits; Rats; Rats, Sprague-Dawley; Thromboxane A2 | 1997 |
The effects of free oxygen radical scavenger and platelet-activating factor antagonist agents in experimental acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Deferoxamine; Disease Models, Animal; Edema; Free Radical Scavengers; Ginkgo biloba; Inflammation; Leukocytes; Luminescent Measurements; Male; Mice; Pancreas; Pancreatitis; Phytotherapy; Plants, Medicinal; Platelet Activating Factor | 1999 |
Effect of the crude extract of Cestrum parqui on carrageenin-induced rat paw oedema and aggregation of human blood platelets.
Topics: Adenosine Diphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Carrageenan; Edema; Male; Pakistan; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Solanaceae | 1999 |
VCAM-1 contributes to rapid eosinophil accumulation induced by the chemoattractants PAF and LTB4: evidence for basal expression of functional VCAM-1 in rat skin.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Chemotaxis, Leukocyte; Dactinomycin; Edema; Eosinophils; Immunoenzyme Techniques; Integrin alpha4; Integrins; Leukotriene B4; Male; Platelet Activating Factor; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Skin; Skin Diseases; Vascular Cell Adhesion Molecule-1 | 1999 |
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Dose-Response Relationship, Drug; Edema; Erythema; Female; Furans; Guinea Pigs; Humans; Lipoxygenase Inhibitors; Mice; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Urea | 2001 |
Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.
Topics: Animals; Aprotinin; Blood Coagulation Factors; Bradykinin; Complement C5a; Dinoprostone; Edema; Fluoroacetates; Histamine Antagonists; Immunoglobulin E; Indomethacin; Lipoxygenase Inhibitors; Male; Neutrophils; Oligopeptides; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Quinolines; Rabbits; Specific Pathogen-Free Organisms | 1992 |
Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antivenins; Crotalid Venoms; Cyclooxygenase Inhibitors; Edema; Foot; Histamine Antagonists; Lipoxygenase Inhibitors; Male; Mice; Opossums; Platelet Activating Factor; Steroids | 1992 |
The role of complement, platelet-activating factor and leukotriene B4 in a reversed passive Arthus reaction.
Topics: Animals; Arthus Reaction; Azepines; Complement System Proteins; Edema; Isoquinolines; Leukotriene B4; Platelet Activating Factor; Rabbits; Radioimmunoassay; Receptors, Complement; Tetrazoles; Triazoles; Zymosan | 1992 |
Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen.
Topics: Allergens; Animals; Antigens; Edema; Injections, Intravenous; Male; Ovalbumin; Platelet Activating Factor; Rabbits; Skin Diseases; Thiazoles | 1992 |
Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Endothelins; Female; Foot; Male; Mice; Platelet Activating Factor; Pleurisy | 1992 |
Differential inhibition by the PAF receptor antagonist, WEB 2170, of allergic inflammation in single sensitized and boosted mice.
Topics: Animals; Antigens; Azepines; Dose-Response Relationship, Drug; Edema; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Triazoles | 1992 |
Effect of PAF-acether antagonists on active anaphylactic mouse paw edema.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Anaphylaxis; Animals; Aspirin; Azepines; Cimetidine; Dexamethasone; Edema; Male; Meclizine; Methysergide; Mice; Ovalbumin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prednisolone; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrazoles; Triazoles | 1991 |
Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide.
Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Capillary Permeability; Complement C5a; Dinoprostone; Drug Synergism; Edema; Histamine H1 Antagonists; In Vitro Techniques; Interleukin-1; Male; Neutrophils; Platelet Activating Factor; Protein Synthesis Inhibitors; Rabbits; Triazoles | 1991 |
Effects of anti-inflammatory drugs on rat hind-paw swelling caused by phospholipase A2 from Naja naja atra venom.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Blood Platelets; Edema; Elapid Venoms; Histamine; Kinins; Leukocytes, Mononuclear; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1991 |
Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Carrageenan; Dextrans; Edema; Histamine Antagonists; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Inbred Strains; Serotonin Antagonists; Zymosan | 1990 |
A role of peripheral leukocytes in vascular permeability and edema formation in air pouch type allergic inflammation in rats.
Topics: Animals; Capillary Permeability; Chemotaxis, Leukocyte; Cyclophosphamide; Dinoprostone; Edema; Hypersensitivity; In Vitro Techniques; Inflammation; Leukocyte Count; Leukocytes; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin; SRS-A | 1991 |
Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Female; Leukocyte Count; Leukocytes; Male; Meclizine; Plant Proteins; Platelet Activating Factor; Pleurisy; Rats; Rats, Inbred Strains; Seeds; Trees | 1991 |
Effects of PAF-antagonists in mouse ear oedema induced by several inflammatory agents.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Ear Diseases; Ear, External; Edema; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Mice; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains | 1991 |
Vascular permeability increase in the mouse paw during the passive anaphylaxis reaction.
Topics: Animals; Capillary Permeability; Edema; Exudates and Transudates; Female; Histamine; Immunoglobulin E; Immunoglobulins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Ovalbumin; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Serotonin | 1991 |
Enterolobin induces rat paw oedema independently of PAF-acether.
Topics: Animals; Azepines; Dihydropyridines; Diterpenes; Edema; Ginkgolides; Lactones; Male; Plant Proteins; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles | 1991 |
Airway oedema and obstruction in guinea pigs exposed to inhaled endotoxin.
Topics: Aerosols; Airway Obstruction; Animals; Azepines; Dust; Edema; Endotoxins; Gossypium; Guinea Pigs; Male; Platelet Activating Factor; Respiration Disorders; Triazoles | 1991 |
The inflammatory actions of platelet activating factor are blocked by levorotatory terbutaline.
Topics: Animals; Blood Pressure; Bradykinin; Dogs; Edema; Histamine; Inflammation; Injections, Intra-Arterial; Lymph; Lymphatic System; Molecular Conformation; Platelet Activating Factor; Receptors, Adrenergic, beta; Terbutaline | 1990 |
Pharmacological modulation of 2-methyl-carbamate-PAF induced rat paw oedema.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbamates; Diterpenes; Edema; Female; Ginkgolides; Lactones; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals.
Topics: alpha-Amylases; Animals; Ceruletide; Diterpenes; Edema; Free Radicals; Ginkgolides; Lactones; Lipid Peroxidation; Male; Oxygen; Pancreatitis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Superoxide Dismutase | 1991 |
Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.
Topics: Animals; Azepines; Bradykinin; Edema; Evans Blue; Exudates and Transudates; Guinea Pigs; Male; Plasma; Platelet Activating Factor; Respiratory Physiological Phenomena; Respiratory System; Triazoles | 1990 |
Further studies on the antinociceptive effects of delta 6-THC-7-oic acid.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Benzoquinones; Copper; Dronabinol; Edema; Female; Humans; Mice; Platelet Activating Factor; Prostaglandins; Reaction Time | 1990 |
Antiallergic and anti-inflammatory action of tioxamast in rats. II. Anti-inflammatory action in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Histamine Antagonists; Male; Oxamic Acid; Platelet Activating Factor; Pleurisy; Rats; Rats, Inbred Strains; Zymosan | 1990 |
Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azepines; Carrageenan; Dose-Response Relationship, Drug; Edema; Exudates and Transudates; Female; Leukocyte Count; Male; Mice; Platelet Activating Factor; Pleurisy; Serotonin; Triazines; Triazoles | 1990 |
Assessment of vascular permeability increase in the mouse by dye leakage during paw edema.
Topics: Animals; Bradykinin; Capillary Permeability; Coloring Agents; Dose-Response Relationship, Drug; Edema; Foot; Histamine; Male; Mice; Mice, Inbred ICR; Phospholipid Ethers; Platelet Activating Factor; Pyrilamine; Tetradecanoylphorbol Acetate | 1990 |
The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
Topics: Animals; Capillary Permeability; Conjunctiva; Edema; Ethanol; Evans Blue; Female; Guinea Pigs; Histamine; Platelet Activating Factor | 1990 |
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capillary Permeability; Complement C5; Complement C5a, des-Arginine; Dinoprostone; Drug Synergism; Edema; Histamine; Inflammation; Injections, Intradermal; Leukotriene B4; Male; N-Formylmethionine Leucyl-Phenylalanine; Nerve Tissue Proteins; Platelet Activating Factor; Prostaglandins E; Rabbits; Rats; Rats, Inbred Lew; Skin; Species Specificity; Substance P | 1985 |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat.
Topics: Animals; Bradykinin; Carrageenan; Dextrans; Edema; Enalapril; Foot; Indoles; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1988 |
Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adrenalectomy; Animals; Annexins; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Carrageenan; Dexamethasone; Dextrans; Edema; Glycoproteins; Indomethacin; Male; Methotrexate; p-Methoxy-N-methylphenethylamine; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pyrazoles; Rats; Rats, Inbred Strains; Recombinant Proteins; Serotonin | 1989 |
Plasma extravasation by chemical mediators in rat skin and trachea: a role of neurogenic agents on tracheal edema formation.
Topics: Animals; Capsaicin; Carbachol; Edema; Histamine; Male; Neurons, Afferent; Platelet Activating Factor; Rats; Rats, Inbred Strains; Skin; Skin Physiological Phenomena; SRS-A; Substance P; Trachea | 1989 |
Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cannabinoids; Dronabinol; Edema; Female; Hydroxyeicosatetraenoic Acids; Mice; Naproxen; Platelet Activating Factor; Structure-Activity Relationship | 1989 |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom.
Topics: Animals; Captopril; Crotalid Venoms; Dexamethasone; Edema; Hot Temperature; Indomethacin; Male; Masoprocol; Platelet Activating Factor; Prazosin; Quinacrine; Rats; Rats, Inbred Strains; Reference Values; Yohimbine | 1989 |
Antagonism of Paf-induced oedema formation in rabbit skin: a comparison of different antagonists.
Topics: Animals; Edema; In Vitro Techniques; Injections, Intradermal; Injections, Intravenous; Male; Platelet Activating Factor; Rabbits; Skin Diseases | 1989 |
Inhibition of Paf-acether-induced edema of the rat's paw.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Calcium Channel Blockers; Edema; Kinetics; Platelet Activating Factor; Rats | 1986 |
Inflammatory mechanisms in the Arthus reaction.
Topics: Animals; Antigen-Antibody Complex; Arthus Reaction; Complement C5; Complement C5a; Dinoprostone; Edema; Histamine H1 Antagonists; Inflammation; Male; Neutrophils; Platelet Activating Factor; Prostaglandins E; Rabbits | 1986 |
A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
Topics: Animals; Arthus Reaction; Capillary Permeability; Chemotactic Factors; Chemotaxis, Leukocyte; Dinoprostone; Edema; Furans; Immunosuppressive Agents; Male; Platelet Activating Factor; Prostaglandins E; Rabbits; Skin | 1986 |
Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate Lipoxygenases; Aspirin; Cyclooxygenase Inhibitors; Dexamethasone; Edema; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salicylates; Sodium Salicylate | 1986 |
Effect of selected antiinflammatory agents and other drugs on zymosan, arachidonic acid, PAF and carrageenan induced paw edema in the mouse.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Carrageenan; Drug Evaluation, Preclinical; Edema; Female; Mice; Platelet Activating Factor; Zymosan | 1987 |
Dexamethasone inhibits platelet activating factor-induced inflammation in the paw but not the pleural cavity of rats.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Dexamethasone; Edema; Female; Foot; Indomethacin; Inflammation; Male; Platelet Activating Factor; Pleura; Pyrazoles; Rats; Rats, Inbred Strains | 1988 |
Adrenalectomy exacerbates paw edema without interfering with desensitization induced by PAF-acether in rats.
Topics: Adrenalectomy; Animals; Corticosterone; Desensitization, Immunologic; Edema; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1988 |
Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021.
Topics: Animals; Diterpenes; Edema; Furans; Ginkgolides; Hypertension, Pulmonary; Injections, Intra-Arterial; Lactones; Lung; Male; Organ Size; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1988 |
Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
Topics: Animals; Bronchial Spasm; Edema; Male; Phthalazines; Platelet Activating Factor; Platelet Aggregation; Pyridazines; Rats; Rats, Inbred Strains | 1988 |
Polymorphonuclear leukocyte-dependent plasma leakage in the rabbit skin is enhanced or inhibited by prostacyclin, depending on the route of administration.
Topics: Alprostadil; Animals; Bradykinin; Complement C5; Complement C5a, des-Arginine; Drug Synergism; Edema; Epoprostenol; Infusions, Parenteral; Injections, Intradermal; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Plasma Volume; Platelet Activating Factor; Rabbits; Skin Diseases | 1986 |
Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Dexamethasone; Edema; Indomethacin; Inflammation; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Thrombocytopenia | 1987 |
Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections.
Topics: Animals; Carbamates; Carrageenan; Drug Tolerance; Edema; Inflammation; Injections; Injections, Intravenous; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin | 1986 |
Platelet involvement in rat paw edema induced by 2-methoxy-PAF.
Topics: Animals; Blood Platelets; Edema; Female; Lysophosphatidylcholines; Male; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema.
Topics: Animals; Anti-Inflammatory Agents; Benzofurans; Benzopyrans; Carrageenan; Edema; Lignans; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Properties of PAF-acether appropriate to a mediator of the inflammatory aspects of asthma.
Topics: Asthma; Edema; Eosinophils; Humans; Inflammation; Platelet Activating Factor | 1985 |